These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 2948055)
1. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis. Burghardt W; Wernze H; Diehl KL Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055 [TBL] [Abstract][Full Text] [Related]
2. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising. Burghardt W; Müller R; Diehl KL; Wernze H Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system. Colantonio D; Casale R; Pasqualetti P Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427 [TBL] [Abstract][Full Text] [Related]
4. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457 [TBL] [Abstract][Full Text] [Related]
5. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide]. Gambini G; Fioroni E; Guerra M; Moscatelli A; Valori C Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200 [TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites. Bonkovsky HL; Hartle DK; Mellen BG; Kutner M; Galambos JT Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574 [TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance. Sellars L; Shore AC; Mott V; Wilkinson R Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077 [TBL] [Abstract][Full Text] [Related]
9. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide. Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404 [TBL] [Abstract][Full Text] [Related]